Can a common arthritis drug tame deadly dengue inflammation?
NCT ID NCT05611710
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 17 times
Summary
This study tests whether anakinra, a drug that reduces inflammation, can help people with severe dengue who have dangerously high levels of inflammation. About 160 hospitalized patients will receive either anakinra or a placebo. The goal is to see if the drug can prevent organ failure and improve recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital for Tropical Diseases
Ho Chi Minh City, Vietnam
Conditions
Explore the condition pages connected to this study.